Submission Details
| 510(k) Number | K993024 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 09, 1999 |
| Decision Date | March 13, 2000 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K993024 is an FDA 510(k) clearance for the CELSITE IMPLANTABLE PORT WITH VALVED CATHETER, a Port & Catheter, Implanted, Subcutaneous, Intravascular (Class II — Special Controls, product code LJT), submitted by B. Braun of America, Inc. (Allentown, US). The FDA issued a Cleared decision on March 13, 2000, 186 days after receiving the submission on September 9, 1999. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5965.
| 510(k) Number | K993024 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 09, 1999 |
| Decision Date | March 13, 2000 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | LJT — Port & Catheter, Implanted, Subcutaneous, Intravascular |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5965 |